Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy

Table 1

Comparison of expression of tissue biomarkers across US-CT and NACT groups.

Biomarker	US-CT group (%)	NACT; group (%)	P value
p53	31 (62%)	29 (58%)	0.419
ER	21 (42%)	24 (48%)	0.344
PR	6 (12%)	4 (8%)	0.37
Bcl2	4 (8%)	8 (16%)	0.178
E-Cadherin	16 (32%)	13 (26%)	0.33
Her-2/neu	0	0	—